Centocor

Results: 172



#Item
21Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI Work Package 5: Supplement 1 to Wave 1 Case Study Report 1:b:iii: Raptiva® (efalizumab)

Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI Work Package 5: Supplement 1 to Wave 1 Case Study Report 1:b:iii: Raptiva® (efalizumab)

Add to Reading List

Source URL: protectbenefitrisk.eu

Language: English - Date: 2014-07-16 01:09:12
22Pharmacology / Medicine / Healthcare in Australia / Pharmaceutical Benefits Scheme / Pharmaceuticals policy / Health / Ruxolitinib / Infliximab / Ustekinumab / Immunosuppressants / Centocor / Monoclonal antibodies

July 2014 PBAC OUTCOMES - Deferrals Drug Name, form(s), strength(s), Sponsor, Type of submission Drug Type and Use

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-01-19 17:21:09
23Successful Outpatient Treatment of Refractory Crohn’s Disease Using Adult Mesenchymal Stem Cells Jane Onken, MD; Dianne Gallup, MS; John Hanson, MD; Michael Pandak, MD; Linda Custer, PhD*, Duke Clinical Research Instit

Successful Outpatient Treatment of Refractory Crohn’s Disease Using Adult Mesenchymal Stem Cells Jane Onken, MD; Dianne Gallup, MS; John Hanson, MD; Michael Pandak, MD; Linda Custer, PhD*, Duke Clinical Research Instit

Add to Reading List

Source URL: www.mesoblast.com

Language: English - Date: 2013-12-30 22:55:11
24aa-sEP-2an 16:18 DEPT OF HERLTH 2u,69

aa-sEP-2an 16:18 DEPT OF HERLTH 2u,69

Add to Reading List

Source URL: www.hkam.org.hk

Language: English - Date: 2014-02-19 00:52:27
25Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Afternoon Session FDA Introductory Remarks Kendall A. Marcus, MD

Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Afternoon Session FDA Introductory Remarks Kendall A. Marcus, MD

Add to Reading List

Source URL: www.fda.gov

Language: English
26Successful Outpatient Treatment of Refractory Crohn’s Disease Using Adult Mesenchymal Stem Cells Jane Onken, MD; Dianne Gallup, MS; John Hanson, MD; Michael Pandak, MD; Linda Custer, PhD*, Duke Clinical Research Instit

Successful Outpatient Treatment of Refractory Crohn’s Disease Using Adult Mesenchymal Stem Cells Jane Onken, MD; Dianne Gallup, MS; John Hanson, MD; Michael Pandak, MD; Linda Custer, PhD*, Duke Clinical Research Instit

Add to Reading List

Source URL: mesoblast.com

Language: English - Date: 2013-12-30 22:55:11
27Severe chronic plaque psoriasis Initial PBS authority application and supporting information Who needs to complete this form

Severe chronic plaque psoriasis Initial PBS authority application and supporting information Who needs to complete this form

Add to Reading List

Source URL: www.humanservices.gov.au

Language: English - Date: 2014-09-09 22:04:36
28Ankylosing spondylitis Continuing PBS authority application Supporting information Purpose of this form Authority prescription form

Ankylosing spondylitis Continuing PBS authority application Supporting information Purpose of this form Authority prescription form

Add to Reading List

Source URL: www.humanservices.gov.au

Language: English - Date: 2015-02-11 18:54:25
29WATAG Advisory Note RE: FORMULARY LISTING OF INFLIXIMAB (REMICADE®) FOR SEVERE ULCERATIVE COLITIS The formulary listing of infliximab for the treatment of ulcerative colitis is hereby approved according to the following

WATAG Advisory Note RE: FORMULARY LISTING OF INFLIXIMAB (REMICADE®) FOR SEVERE ULCERATIVE COLITIS The formulary listing of infliximab for the treatment of ulcerative colitis is hereby approved according to the following

Add to Reading List

Source URL: www.watag.org.au

Language: English - Date: 2012-12-16 22:40:24
30Therapeutic Area Central Nervous System JOHNSON & JOHNSON SELECTED PHARMACEUTICALS IN LATE STAGE U.S. and E.U. DEVELOPMENT OR REGISTRATION As of January 25, 2011*

Therapeutic Area Central Nervous System JOHNSON & JOHNSON SELECTED PHARMACEUTICALS IN LATE STAGE U.S. and E.U. DEVELOPMENT OR REGISTRATION As of January 25, 2011*

Add to Reading List

Source URL: files.shareholder.com

Language: English